Work

Validation of Fructosamine-to-HbA1c Conversion Formulas Using Continuous Glucose Monitoring in Surgical Patients

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Purpose To compare the performance of four published fructosamine-to-HbA1c conversion formulas against continuous glucose monitoring (CGM) data in patients undergoing preoperative diabetes optimization. Methods This retrospective, cross-sectional study included 30 patients enrolled in a preoperative diabetes optimization program who had both fructosamine values and at least 14 days of overlapping CGM data. Four previously published conversion formulas (Cohen, Wright-Hirsch, Kang, and Young) were evaluated. Pearson correlation analysis examined relationships between fructosamine-derived estimated HbA1c values and CGM-derived glucose management indicator (GMI). Results Mean fructosamine was 331.2 ± 70.6 µmol/L, mean CGM glucose was 165.8 ± 34.4 mg/dL, and mean GMI was 7.28% ± 0.82%. Fructosamine demonstrated significant positive correlation with average CGM glucose (r = 0.39, p = 0.04). All four conversion formulas showed similar, statistically significant correlations with GMI (r ≈ 0.39, p ≈ 0.03). Conclusions All four fructosamine conversion formulas demonstrated comparable performance when validated against CGM data in the preoperative setting. These findings support the clinical utility of fructosamine for short-term glycemic assessment when HbA1c may be unreliable or when recent glycemic changes are clinically relevant, in absence of or when unable to use CGM.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7235511354
Cites: 23
Cited by:
Related to: 10